ALPHARETTA, Ga., March 6,
2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:
AVNS) today announced that Dr. Lisa
Egbuonu-Davis, currently vice president, medical
innovations, for DH Diagnostics, LLC, an affiliate of Danaher
Corporation, has been appointed as a new independent member of the
Avanos board of directors and will serve as a member of the
compliance and governance committees.
"We are pleased and excited to welcome Lisa Egbuonu-Davis to the Avanos board,"
commented Gary Blackford, Avanos
board chair. "Her deep strategic and operational expertise in the
healthcare sector will be invaluable to Avanos as we continue to
develop our business and pursue our mission to get patients back to
the things that matter."
"I feel strongly that population health is everyone's
responsibility, and Avanos is committed to creating innovative
healthcare solutions to address some of today's most important
healthcare needs, including reducing the use of opioids," said
Egbuonu-Davis. "I am thrilled to join its board as a new
independent director."
From 2015 to 2019, Egbuonu-Davis served as vice president,
global patient centered outcomes and solutions, at Sanofi, Inc.,
where she created patient programs, services, and tools to enhance
health outcomes in patients with chronic conditions.
Prior to Sanofi, Egbuonu-Davis co-founded and served as director
for ROI Squared, LLC, a privately held life science company focused
on diagnostic medical devices, and served as managing director for
LED Enterprise, LLC, where she advised biopharmaceutical companies
and trade associations on healthcare reform, technology assessment,
quality metrics, and incentives and implications for research and
services.
She also served in senior advisor roles for Avalere Health and
Booz Allen Hamilton, as well as in
various roles over 13 years at Pfizer, Inc., where she led clinical
and outcomes research departments, supported product value
assessments in support of reimbursement and adoption, and
influenced product investment and development decisions.
Egbuonu-Davis earned a bachelor's degree in biology from
MIT and an MBA in healthcare management
from Wharton, as well as an M.D.
and an M.S. in public health from Johns
Hopkins. She completed her pediatric residency at Children's
Hospital of Philadelphia
(board-certified in pediatrics). She has served on the Johns
Hopkins Medicine board of trustees since 2021 and the national
advisory council for the Johns Hopkins
University School of Education since 2007.
With this new appointment, the Avanos board now comprises six
directors, five of whom are independent, including two women, one
of whom is ethnically diverse.
About Avanos Medical, Inc.
Avanos Medical, Inc. (NYSE: AVNS) is a medical technology
company focused on delivering clinically superior medical device
solutions that will help patients get back to the things that
matter. Headquartered in Alpharetta,
Georgia, we are committed to addressing some of today's most
important healthcare needs, including providing a vital lifeline
for nutrition to patients from hospital to home, and reducing the
use of opioids while helping patients move from surgery to
recovery. We develop, manufacture and market our recognized brands
globally and hold leading market positions in multiple categories
across our portfolio. For more information, visit
Avanos.com and follow Avanos Medical on Twitter
(@AvanosMedical), LinkedIn and Facebook.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-appoints-dr-lisa-egbuonu-davis-to-board-of-directors-301762853.html
SOURCE Avanos Medical, Inc.